Weichang Zhou
Director/Board Member en WUXI BIOLOGICS (CAYMAN) INC. .
Fortuna: 451 558 $ al 31/03/2024
Cargos activos de Weichang Zhou
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | 01/05/2016 | - |
Chief Tech/Sci/R&D Officer | 01/11/2016 | 31/03/2024 | |
WUXI XDC CAYMAN INC. | Director/Board Member | 01/12/2020 | - |
Historial de carrera de Weichang Zhou
Antiguos cargos conocidos de Weichang Zhou.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Board Member | 01/03/2008 | 01/12/2012 |
PDL BIOPHARMA, INC. | Director/Board Member | 01/10/2002 | 01/02/2008 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/05/1994 | 01/10/2002 |
Formación de Weichang Zhou.
University of Hannover | Doctorate Degree |
Jiangxi University of Science & Technology | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
China | 3 |
Alemania | 2 |
Operativa
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
WUXI XDC CAYMAN INC. | Commercial Services |
Empresas privadas | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Bolsa de valores
- Insiders
- Weichang Zhou
- Experiencia